Indication extrapolation for anti-TNF biosimilars | Nature Reviews Gastroenterology & Hepatology
Internet Scientific Publications
References in Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management - The Lancet Infectious Diseases
![ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents) -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9c2bef2d-312b-4053-ba48-b71a92fccf08/gr1_lrg.jpg "ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents) -")
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents) -
The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease
Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement | European Respiratory Society
Schematic of TNF inhibitors and their mode of action. Receptor (i.e.... | Download Scientific Diagram
Frontiers | Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology | Immunology
Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling | Gut
Mechanism of action of anti-tumor necrosis factor biologics and... | Download Scientific Diagram
Frontiers | The TNF Paradox in Cancer Progression and Immunotherapy | Immunology
Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?
Schematic illustrations summarizing similarities and differences... | Download Scientific Diagram
Tumor Necrosis Factor (TNF) Inhibitors | SpringerLink
Mechanism of Action, Pharmacokinetics, and Drug Interactions of Etanercept in Dermatology | Semantic Scholar
Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls | Immunotherapy
Anti-TNF therapy | Musculoskeletal Key
Cureus | Biologic Therapies in Sarcoidosis and Uveitis: A Review
TNF-alpha Inhibitors - MSK - Medbullets Step 1
TNFa 억제제 비교 etanercept, adalimumab, infliximab, certolizumab, tanfanercept HL036 : 네이버 블로그
Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF | Annals of the Rheumatic Diseases
Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls | Immunotherapy
